OOIR: Observatory of International Research

Papers

(The TQCC of European Journal of Contraception and Reproductive Health Care is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-07-01 to 2026-07-01.)

Article	Citations
A pioneer of hormonal contraception: Joseph W. Goldzieher	151
Modern contraceptive use among women of reproductive age in Zimbabwe: analysis of 1999–2015 Zimbabwe Demographic Health Survey	47
Correction	38
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]	21
Family planning and contraception in women of reproductive age with systemic lupus erythematosus: a narrative review	19
How often is oral contraception used for contraception? The need of benefit’s formalisation	19
Patient acceptability of intra-amniotic digoxin versus intracardiac lidocaine for inducing foetal demise prior to second trimester medical abortion: a prospective cohort	15
Hypertension and smoking as contraindications to combined hormonal contraception but not to postmenopausal hormone therapy: but natural oestrogens (oestradiol and estetrol) are the same!	15
Measurement of pain during first trimester medical abortion: an exploratory qualitative study	14
Investigating barriers to effective contraceptive use in Sub-Saharan Africa and addressing associated challenges	14
The prolonged-release oral formulations: a new era in hormonal contraception technology?	13
Labour induction for termination of pregnancy with severe fetal anomalies after 24 weeks’ gestation: a case series and systematic review of the literature	12
Effect of antenatal contraceptive education and other factors on uptake of long-acting reversible contraception in postpartum women in Hong Kong	12
Knowledge of contraceptive methods among deaf women: a qualitative study	11
Improving access to postpartum contraception – a review of global guidelines with ESCRH consensus recommendations for Europe	10
The far-reaching impact of abortion bans: reproductive care and beyond	9
Contraceptive switch and abandonment among women using the pill, condoms and injectables in Brazil	9
Perception of oral contraception – do women think differently from gynaecologists?	9
A titrated low-dose misoprostol protocol for second-trimester abortion (13–26 weeks) in women with one prior cesarean and preterm premature rupture of membranes: a clinical practice report	8
Factors affecting age at menopause and their relationship with ovarian reserve: a comprehensive review	8
Improvement of laboratory markers of anaemia in the treatment of heavy menstrual bleeding with a 19.5-mg intrauterine device: a pilot study	8
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure ^® implant removal: a cross-sectional study	7
Asked but not received: postpartum contraception access in opioid-using pregnant patients	7
Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?]	7
Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial]	6

Evaluating the fidelity of AI-generated information on long-acting reversible contraceptive methods	6
The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain	6
The criminalisation of women’s healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes	6
Sequential treatment with relugolix combination therapy in women with symptomatic uterine fibroids that were inadequately managed with 52 mg levonorgestrel intrauterine system: the first report	6
Women’s decision-making related to induced abortion – a cross sectional study during a period of Covid-19 pandemic, in Sweden	6
The preferences of women in Australia for the features of long-acting reversible contraception: results of a discrete choice experiment	6
“Better late than never but never late is better”, especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosis	6
Advancing access, evidence, and equity in abortion care	5
Optimising contraceptive counselling: insights for obesity and bariatric surgery patients	5
Does change in the shape of intrauterine contraceptive device Cu 375 and Cu T 380A affect the expulsion after post-partum insertion – a prospective randomized control trial	5
Experiences and impacts of side effects among contraceptive users in the UK: exploring individual narratives of contraceptive side effects	5
Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder	5
Narratives of men and women from the southeastern region of Brazil on some aspects of sexual and reproductive health, sexual life and contraception: a qualitative study	5
The pre- Roe legal framework: a dissecting study of the evolution of abortion laws and their socio-legal implications	5
Clinical improvement after Essure® devices removal: a systematic review	4
Access to abortion in a cross-border region in the Eastern Pyrenees: the case of Hospital de Cerdanya, between Spanish and French legislation	4
We don´t have elements to scare women who use oral contraceptives based on nomegestrol or chlormadinone about the risk of meningioma. Let's be careful and honest!	4
Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age – a systematic review	4
The impact of using the levonorgestrel-releasing intrauterine device on the incidence of acne in adolescents and young women	4
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction	4
Retraction Notice	4
Statement of Retraction: “Correlation between uterine artery Doppler indices and menstrual irregularities among levonorgestrel releasing intrauterine system and depot medroxyprogesterone acetate users	4
Pharmacist recommendations for emergency contraception in Belgium: a simulated user study	4
Impact of abortion bans on pregnancies with severe life-limiting foetal anomalies in the United States: a cost-effectiveness analysis	4
Beyond dietary habits: ultra-processed food consumption reveals the association with HPV infection in U.S. women	4
A pilot randomised study to compare sub-lingual and vaginal routes of low-dose misoprostol following two sequential doses of mifepristone for second-trimester medical abortion	4
Retraction	4
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition	4
Correlation of sexual desire with sexual hormone binding globulin and free androgen index in women using combined contraceptives	4
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic	4
Views, attitudes and experiences of South Asian women concerning sexual health services in the UK: a qualitative study	3
Comments on: ‘Critical assessment of a prolonged-release EE/DNG contraceptive safety analysis’ - a letter to the editor to the European Jornal of Contraception by Jonathan Douxfils et al	3
Editors’ response	3
From hesitancy to hope: charting India’s path to widespread HPV immunisation	3
Usage of postpartum intrauterine contraceptive device (postpartum-IUD) after an increase in the institutional delivery rate in India: time to re-visit the effect of timing of counselling on its accept	3
Legal abortion requests and outcomes for women when the law is restrictive – experience from a referral centre in south-eastern Brazil	3
Knowledge, professional attitudes, and training among health professionals regarding male contraceptive methods	3
Can transvaginal cervical length and cervical strain elastography predict mid-trimester medical induction to abortion intervals?	3
High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy	3
Intrauterine devices and gynaecological malignancies - an umbrella review of systematic reviews and meta-analyses	3
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review	3
‘Do I want children later in life?’ Reproductive intentions of 1700 adolescents	3
Depomedroxyprogesterone acetate impact on mifepristone action during medication abortion	3
Contraception for adolescent and young women. A consensus conference results	3
Onset and recovery from depressive mood changes on progestin treatment - a case series reporting the course and type of depressive symptoms in progestin users with different histories and risks	3
Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients	3
Correction	3
Fertility awareness, reproductive autonomy and what people should know about having children	3
Medical termination of pregnancy: people’s expectations and experiences in the Netherlands	3
Ulipristal acetate for medical abortion: did we really need to create a ‘monster’?	3

Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours	3
Expression of Concern	3